Ion channel targets
Print ISSN 1933-6950; Online ISSN 1933-6969

Recommend Channels to your librarian for 2008. Download form here.

Sign up for Table of Contents Alerts.

home subscribe search archive forthcoming

Email this page Print this page

Addenda

Selective Downregulation of the BKβ1 Subunit in Diabetic Arteriolar Myocytes

Mary K. McGahon, Xiaohong Zhang, C. Norman Scholfield, Timothy M. Curtis and J. Graham McGeown

volume 1 | issue 3

May/June 2007
Pages: 141 - 143

This is an open-access article

 Download PDF

If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.

Diabetic retinopathy is an important cause of visual loss. Functional abnormalities including vasoconstriction precede structural changes. Using the streptozotocin-model of diabetes in rats, we have identified down-regulation of the β1 subunit of the BK channel in arteriole myocytes as a possible molecular mechanism underlying these early changes. BKβ1 mRNA levels were reduced as early as 1 month after induction of diabetes, and BK Ca2+-sensitivity and caffeine-evoked BK currents were reduced at 3 months. This effect appears to be selective for the regulatory subunit, as BKα subunit expression was not altered at the mRNA level, and voltage-activated BK currents were unaltered. No changes were seen in voltage activated Ca2+-current, Ca2+-activated Cl--current, or A-type voltage activated K+-currents. Reduced Ca2+-activated BK activity may promote depolarization, Ca2+-channel activation and increased contraction under resting conditions or in response to Ca2+-mobilizing agonists.

Authors

Mary K. McGahon

Centre for Vision Sciences; School of Biomedical Sciences; The Queen's University of Belfast, Institute of Clinical Sciences; The Royal Victoria Hospital; Belfast, UK

Xiaohong Zhang

Centre for Vision Sciences; School of Biomedical Sciences; The Queen's University of Belfast, Institute of Clinical Sciences; The Royal Victoria Hospital; Belfast, UK

C. Norman Scholfield

Cell and Metabolic Signaling Group; School of Medicine and Dentistry; The Queen's University of Belfast; Belfast, UK

Timothy M. Curtis

Centre for Vision Sciences; School of Biomedical Sciences; The Queen's University of Belfast, Institute of Clinical Sciences; The Royal Victoria Hospital; Belfast, UK

J. Graham McGeown

Cell and Metabolic Signaling Group; School of Medicine and Dentistry; The Queen's University of Belfast; Belfast, UK


This is an open-access article

 Download PDF

If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.